Prestige Consumer Healthcare Inc. Stock
The price for the Prestige Consumer Healthcare Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.500 (-0.970%).
Currently there is a rather positive sentiment for Prestige Consumer Healthcare Inc. with 5 Buy predictions and 0 Sell predictions.
With a target price of 78 € there is a hugely positive potential of 52.94% for Prestige Consumer Healthcare Inc. compared to the current price of 51.0 €.
Pros and Cons of Prestige Consumer Healthcare Inc. in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prestige Consumer Healthcare Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prestige Consumer Healthcare Inc. | -0.970% | 3.239% | 2.823% | -35.032% | -31.544% | -11.304% | 70.000% |
| Apollo Medical Holdings, Inc. | 4.740% | 0.529% | 3.261% | -46.629% | -39.103% | -30.403% | - |
| Petmed Express Inc | 4.120% | 77.431% | 45.560% | -52.381% | -49.228% | -86.014% | -90.032% |
| Suzuken Co Ltd | - | 34.700% | 34.700% | 34.700% | 34.700% | 34.700% | 8.629% |
Comments
Prestige Consumer Healthcare (NYSE:PBH) had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $82.00 to $72.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare (NYSE:PBH) was upgraded by analysts at Sidoti from a "neutral" rating to a "buy" rating. They now have a $80.00 price target on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for PBH provided by MarketBeat